BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-19.01%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$911M
AUM Growth
+$911M
(-27%)
Cap. Flow
-$42.3M
Cap. Flow
% of AUM
-4.65%
Top 10 Holdings %
Top 10 Hldgs %
87.82%
Holding
27
New
1
Increased
6
Reduced
4
Closed
2
Top Buys
| 1 |
Disc Medicine
IRON
|
$21.6M |
| 2 |
Century Therapeutics
IPSC
|
$13.8M |
| 3 |
Kyverna Therapeutics
KYTX
|
$1.53M |
| 4 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$1.02M |
| 5 |
Xilio Therapeutics
XLO
|
$929K |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$52.6M |
| 2 |
Nurix Therapeutics
NRIX
|
$16.6M |
| 3 |
Arcutis Biotherapeutics
ARQT
|
$9.12M |
| 4 |
Aclaris Therapeutics
ACRS
|
$2.2M |
| 5 |
Annexon
ANNX
|
$1.24M |
Sector Composition
| 1 | Healthcare | 99.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$5.52B
| $205M | 22.46% | 2,697,267 | – | – |
|
2
NewAmsterdam Pharma
NAMS
$2.71B
| $201M | 22.09% | 10,473,913 | – | – |
|
|
3
Disc Medicine
IRON
$2.07B
| $80.9M | 8.89% | 1,795,735 +478,522 | +36% | +$21.6M |
|
4
Dianthus Therapeutics
DNTH
$759M
| $78M | 8.56% | 3,013,423 +21,395 | +0.7% | +$554K |
|
5
Pharvaris
PHVS
$1.39B
| $62.1M | 6.82% | 3,303,381 | – | – |
|
6
Savara
SVRA
$567M
| $58.7M | 6.44% | 14,565,457 | – | – |
|
|
7
Annexon
ANNX
$226M
| $41.4M | 4.55% | 8,449,208 -254,060 | -3% | -$1.24M |
|
|
8
Kyverna Therapeutics
KYTX
$160M
| $25.3M | 2.77% | 3,368,370 +204,502 | +6% | +$1.53M |
|
9
Tango Therapeutics
TNGX
$747M
| $24.8M | 2.72% | 2,892,663 | – | – |
|
10
Solid Biosciences
SLDB
$427M
| $22.9M | 2.51% | 4,034,582 | – | – |
|
11
Mersana Therapeutics
MRSN
$36.5M
| $17.4M | 1.91% | 8,663,673 | – | – |
|
|
SYRS
12
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $14.2M | 1.56% | 2,749,808 | – | – |
|
|
13
Century Therapeutics
IPSC
$42.5M
| $13.8M | 1.51% | +5,410,361 | New | +$13.8M |
|
14
Cabaletta Bio
CABA
$133M
| $12.3M | 1.36% | 1,649,964 +32,600 | +2% | +$244K |
|
15
X4 Pharmaceuticals
XFOR
$84.2M
| $9.81M | 1.08% | 16,915,784 | – | – |
|
|
16
Arcutis Biotherapeutics
ARQT
$1.86B
| $9.59M | 1.05% | 1,030,703 -980,984 | -49% | -$9.12M |
|
17
Atea Pharmaceuticals
AVIR
$267M
| $8.23M | 0.9% | 2,485,638 | – | – |
|
18
Rapid Micro Biosystems
RPID
$107M
| $5.57M | 0.61% | 8,434,560 | – | – |
|
19
C4 Therapeutics
CCCC
$185M
| $5.14M | 0.56% | 1,111,910 -30,300 | -3% | -$140K |
|
20
Nautilus Biotechnolgy
NAUT
$85.9M
| $4.68M | 0.51% | 2,000,000 | – | – |
|
|
21
Xilio Therapeutics
XLO
$36.3M
| $3.59M | 0.39% | 3,785,450 +980,037 | +35% | +$929K |
|
|
MRNS
22
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2.65M | 0.29% | 2,267,680 +874,300 | +63% | +$1.02M |
|
23
Invivyd
IVVD
$204M
| $1.98M | 0.22% | 1,799,595 | – | – |
|
|
24
Aclaris Therapeutics
ACRS
$209M
| $1.1M | 0.12% | 1,000,000 -2,000,000 | -67% | -$2.2M |
|
|
25
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$58.3M
| $872K | 0.1% | 100,000 | – | – |
|